Pneumothorax presentation in endometrial sarcoma patients receiving chemotherapy: A case series.

Angela Duvalyan, Kirk Tran, Christopher Lee, Shefali Chopra, James Hu

Open access · goldAbstract readCase Reports

In one paragraph

Article in Rare tumors, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

0.1field-weighted citation impact, top 45% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 1 country.

Angela DuvalyanThe University of Texas Southwestern Medical Center, Dallas, TX, USA.

Kirk TranEastern Virginia Medical School, Norfolk, VA, USA.

Christopher LeeCedars-Sinai Medical Center, Los Angeles, CA, USA.

Shefali ChopraKeck Hospital of USC, Los Angeles, CA, USA.

James HuNorris Comprehensive Cancer Center, Los Angeles, CA, USA.ORCID https://orcid.org/0000-0003-0620-4664

Cedars-Sinai Medical Center · USEastern Virginia Medical School · USKeck Hospital of USC · USThe University of Texas Southwestern Medical Center · USUSC Norris Comprehensive Cancer Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Endometrial stromal sarcomas (ESS) account for 10-15% of uterine malignancies and are classified into four categories: endometrial stromal nodule (ESN), low-grade endometrial stromal sarcoma (LG-ESS), high-grade endometrial stromal sarcoma (HG-ESS) and undifferentiated uterine sarcoma (USS). Depending on stage, ESS is treated with surgery, hormone therapy, chemotherapy or targeted therapy. A rare complication of ESS with metastatic pulmonary disease is recurrent, bilateral pneumothoraces. The current literature has reported on patients with ESS who either presented with pneumothoraces at their initial diagnosis, and thus were untreated, or after treatment with surgical resection and hormone therapy. There have been no case reports of patients with ESS who presented with pneumothoraces while receiving chemotherapy. Furthermore, there have been no reported cases of patients with HG-ESS presenting with this rare complication. We would like to expand the literature by reporting on two patients with HG-ESS who presented with pneumothoraces while concurrently receiving chemotherapy.

Indexed as

cavitary lesionchemotherapyEndometrial stromal sarcomahigh-grade endometrial stromal sarcomapneumothoraxpulmonary metastasis

Identifiers

PMID34394884

DOI10.1177/2036361320972865

PMCPMC8351025

OpenAlexW3109544318

What OpenQuestion holds

Textmetadata

LicenceCC BY-NC

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.